Integra LifeSciences Holdings Corporation
IART
$13.09
$0.030.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.26% | 8.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.26% | 8.61% | |||
| Cost of Revenue | -7.61% | 11.29% | |||
| Gross Profit | 0.28% | 6.53% | |||
| SG&A Expenses | -2.41% | 7.21% | |||
| Depreciation & Amortization | -0.69% | 1.35% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.42% | 9.04% | |||
| Operating Income | 22.09% | 3.80% | |||
| Income Before Tax | 98.71% | -1,667.72% | |||
| Income Tax Expenses | 96.97% | -888.38% | |||
| Earnings from Continuing Operations | 98.88% | -1,813.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 98.88% | -1,813.86% | |||
| EBIT | 22.09% | 3.80% | |||
| EBITDA | 11.44% | 2.47% | |||
| EPS Basic | 98.88% | -1,808.01% | |||
| Normalized Basic EPS | 41.60% | -14.38% | |||
| EPS Diluted | 98.88% | -1,808.01% | |||
| Normalized Diluted EPS | 41.60% | -14.38% | |||
| Average Basic Shares Outstanding | 0.08% | 0.30% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||